Journal of Cataract & Refractive Surgery
Volume 33, Issue 1 , Pages 63-68 , January 2007

Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients

,Accepted 3 September 2006.

References 

  1. Masket S. Preventing, diagnosing, and treating endophthalmitis. [guest editorial] J Cataract Refract Surg. 1998;24:725–726
  2. Gills JP. Filters and antibiotics in irrigating solution for cataract surgery. [letter] J Cataract Refract Surg. 1991;17:385
  3. Gimbel HV, Sun R, de Brof BM. Prophylactic intracameral antibiotics during cataract surgery: the incidence of endophthalmitis and corneal endothelial cell loss. Eur J Implant Refract Surg. 1994;6:280–285
  4. Gimbel HV, Sun R. Prophylactic intracameral vancomycin and CME. [letter] Ophthalmology. 2000;107:1614–1615
  5. Axer-Siegel R, Stiebel-Kalish H, Rosenblatt I, et al. Cystoid macular edema after cataract surgery with intraocular vancomycin. Ophthalmology. 1999;106:1660–1664
  6. Seppälä H, Al-Juhaish M, Järvinen H, et al. Effect of prophylactic antibiotics on antimicrobial resistance of viridans streptococci in the normal flora of cataract surgery patients. J Cataract Refract Surg. 2004;30:307–315
  7. Centers for Disease Control . Staphylococcus aureus resistant to vancomycin—United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:565–567
  8. Barry P, Seal DV, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg. 2006;32:407–410
  9. Seal DV, Barry P, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: case for a European multicenter study; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg. 2006;32:396–406
  10. Mamalis N, Edelhauser HF, Dawson DG, et al. Toxic anterior segment syndrome. J Cataract Refract Surg. 2006;32:324–333
  11. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002;133:463–466
  12. Kowalski RP, Romanowski EG, Mah FS, et al. Intracameral Vigamox® (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol. 2005;140:497–504
  13. Stroman DW, Dajcs JJ, Cupp GA, Schlech BA. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%; a new topical fluoroquinolone. Surv Ophthalmol. 2005;50(suppl):S16–S31
  14. Trinkhaus-Randall V, Edelhauser HF, Leibowitz HM, Freddo TF. Corneal structure and function. In:  Leibowitz HM,  WaringIII GO editor. Corneal Disorders; Clinical Diagnosis and Management. 2nd ed.. Philadelphia, PA: WB Saunders; 1998;p. 21–27
  15. Gonnering R, Edelhauser HF, Van Horn DL, Durant W. The pH tolerance of rabbit and human corneal endothelium. Invest Ophthalmol Vis Sci. 1979;18:373–390
  16. Edelhauser HF, Hanneken AM, Pederson HJ, Van Horn DL. Osmotic tolerance of rabbit and human corneal endothelium. Arch Ophthalmol. 1981;99:1281–1287
  17. Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis: Fundamentals and Clinical Practice. 2nd ed.. St Louis, MO: Mosby-Year Book; 1996;61–62
  18. West ES, Behrens A, McDonnell PJ, et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population between 1994 and 2001. Ophthalmology. 2005;112:1388–1394
  19. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update. Ophthalmology. 2002;109:13–24questions for CME credit request, 25–26
  20. Isenberg SJ, Apt L, Yoshimori R, et al. Efficacy of topical povidone-iodine during the first week after ophthalmic surgery. Am J Ophthalmol. 1997;124:31–35
  21. Alfonso E, Crider J. Ophthalmic infections and their anti-infective challenges. Surv Ophthalmol. 2005;50(suppl):S1–S6
  22. Schlech BA, Alfonso E. Overview of the potency of moxifloxacin ophthalmic solution 0.5% (Vigamox®). Surv Ophthalmol. 2005;50(Suppl):S7–S15
  23. O'Brien PD, Fitzpatrick P, Kilmartin DJ, Beatty S. Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident. J Cataract Refract Surg. 2004;30:839–843
  24. Montan PG, Wejde G, Setterquist H, et al. Prophylactic intracameral cefuroxime: evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg. 2002;28:982–987
  25. Peyman GA, Sathar ML, May DR. Intraocular gentamicin as intraoperative prophylaxis in South India eye camps. Br J Ophthalmol. 1977;61:260–262
  26. Kramann C, Pitz S, Schwenn O, et al. Effects of intraocular cefotaxime on the human corneal endothelium. J Cataract Refract Surg. 2001;27:250–255
  27. Cheng H, Bates AK, Wood L, McPherson K. Positive correlation of corneal thickness and endothelial cell loss; serial measurements after cataract surgery. Arch Ophthalmol. 1988;106:920–922
  28. Amon M, Menapace R, Radax U, Papapanos P. Endothelial cell density and corneal pachymetry after no-stitch, small-incision cataract surgery. Doc Ophthalmol. 1992;81:301–307
  29. Mindel JS. Pharmacokinetics. In:  Tasman W,  Jaeger EA editor. Duane's Foundations of Clinical Ophthalmology on CD-ROM. Philadelphia, PA: Lippincott Williams & Wilkins; 2006;vol. 3, chap 23
  30. Schentag JJ. Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: moxifloxacin and Streptococcus pneumoniae. J Chemother. 2002;14(suppl 2):13–21
  31. Metzler K, Hansen GM, Hedlin P, et al. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus. Int J Antimicrob Agents. 2004;24:161–167
  32. Ferro JF, de-Pablos M, Logroño MJ, et al. Postoperative contamination after using vancomycin and gentamicin during phacoemulsification. Arch Ophthalmol. 1997;115:165–170
  33. Lehmann OJ, Thompson JP, White LO, et al. Half-life of intracameral gentamicin after phacoemulsification. J Cataract Refract Surg. 1997;23:883–888
  34. Mendívil Soto A, Mendívil MP. The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery. Am J Ophthalmol. 2001;131:293–300

 Presented as a poster at the 21st Congress of the Asia Pacific Academy of Ophthalmology 2006, Singapore, Singapore, June 2006.No author has a propriety or financial interest in any material or method mentioned.

PII: S0886-3350(06)01276-4

doi: 10.1016/j.jcrs.2006.09.019

Journal of Cataract & Refractive Surgery
Volume 33, Issue 1 , Pages 63-68 , January 2007

Article Tools

* Image Usage & Resolution